Information date: 15 October 2026 — China taxes equity incentives at vesting, exercise, or buyout, depending on instrument. Listed-company stock options, restricted stock and RSUs are generally eligible for separate-rate treatment: the taxable income is divided by a months factor derived from the vesting schedule, matched to the comprehensive income tax table, then multiplied back. Unlisted-company incentives are taxed similarly but with a filing requirement; where an incentive does not qualify, the gain folds into comprehensive income and can push the recipient into a higher bracket. Knowing that statement is not enough for an operating, research or compliance decision. The team must first establish who and what it applies to, how the effect reaches the real process, and which evidence would justify action.
Verified facts and scope
China taxes equity incentives at vesting, exercise, or buyout, depending on instrument. Listed-company stock options, restricted stock and RSUs are generally eligible for separate-rate treatment: the taxable income is divided by a months factor derived from the vesting schedule, matched to the comprehensive income tax table, then multiplied back. Unlisted-company incentives are taxed similarly but with a filing requirement; where an incentive does not qualify, the gain folds into comprehensive income and can push the recipient into a higher bracket.
Applies to China-tax-resident employees and to foreign nationals meeting the residence tests, and to listed and unlisted designs. Before calculating, collect the plan documents, grant and vest dates, exercise or settlement price, fair market value on each vesting date, the months factor applicable to the instrument, and whether the employer withholds through the payroll system.
How the effect reaches operations
Because the formula uses a months factor rather than the actual holding period, splitting a grant into many small tranches lowers the effective rate while a single large vesting concentrates income in one bracket. The employer is the withholding agent and must remit by the statutory payroll deadline; if the employer advances the tax, the advance itself can be a taxable benefit unless properly documented.
Frequent errors: computing on the number of months the employee held the shares instead of the plan's vesting factor; treating a cash-settled or buyout event as a capital gain rather than employment income; failing to recalculate when the withholding agent changes mid-year; and overlooking that a foreign employee's departure or a residence-status change alters the whole computation.
For “Payroll Tool: China IIT Withholding on Equity Incentives — Computing Tax on RSU Vesting, Option Exercise and ESOP Buyouts”, official rules or published findings, direct evidence from the relevant product or process, and assumptions that remain untested should be recorded separately. A broad source defines the external boundary; it does not replace batch records, protocols, contracts, labels or direct observations.
Decision
Build the calculation around the vesting event date, not the grant or sale date. If the participant is a foreign national approaching a residence threshold, or the entity is unlisted, model both separate-rate and comprehensive treatment and keep the conservative one for withholding, adjusting on annual settlement. Where several tranches vest in one year, test whether re-sequencing future grants reduces bracket creep.
Implementation checklist
- Collect grant, vest and settlement documents before the payroll cut-off date.
- Run the months-factor calculation and reconcile it with the annual settlement.
- Record the fair market value source used for each vesting date.
- Assign one decision owner, one implementation owner and a dated review point for “Payroll Tool: China IIT Withholding on Equity Incentives — Computing Tax on RSU Vesting, Option Exercise and ESOP Buyouts”.
- For “Payroll Tool: China IIT Withholding on Equity Incentives — Computing Tax on RSU Vesting, Option Exercise and ESOP Buyouts”, archive the source page, access date, applicable population or entity, and internal evidence both supporting and opposing the current decision.
- When a rule, formulation, supplier, protocol or observed result changes, reopen only the affected question in “Payroll Tool: China IIT Withholding on Equity Incentives — Computing Tax on RSU Vesting, Option Exercise and ESOP Buyouts”.
Evidence and review
For “Payroll Tool: China IIT Withholding on Equity Incentives — Computing Tax on RSU Vesting, Option Exercise and ESOP Buyouts”, start with one real case rather than an abstract checklist. Record the input version, responsible owner, start time, observed result and stop condition. If the team cannot complete “Collect grant, vest and settlement documents before the payroll cut-off date.” with current evidence, it should not expand the process to more products, patients, suppliers or markets. The first review should focus only on facts capable of changing the decision.
The second control follows “Run the months-factor calculation and reconcile it with the annual settlement.”. Keep the source date, applicable population or entity, deadline, cost effect and owner in the same evidence file. A wording preference does not justify a new version. A repeated discrepancy, an unsupported health claim or a regulatory mismatch does: correct that point and hold release until the evidence is available.
After “Record the fair market value source used for each vesting date.”, compare the intended outcome with what actually happened. Apply the same success criteria to each later expansion. If only one number, date or responsibility changes, update that field and the affected conclusion instead of recreating evidence that remains valid. This keeps the decision traceable without turning review into an open-ended rewrite cycle.
Limits of the conclusion
This tool describes a calculation approach and is not tax advice; the applicable treatment depends on the plan's qualification, the listing status of the company and the individual's residence status.
